186 related articles for article (PubMed ID: 24338022)
1. Naturally occurring variants of the dysglycemic peptide pancreastatin: differential potencies for multiple cellular functions and structure-function correlation.
Allu PK; Chirasani VR; Ghosh D; Mani A; Bera AK; Maji SK; Senapati S; Mullasari AS; Mahapatra NR
J Biol Chem; 2014 Feb; 289(7):4455-69. PubMed ID: 24338022
[TBL] [Abstract][Full Text] [Related]
2. Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic Disorders.
Allu PKR; Kiranmayi M; Mukherjee SD; Chirasani VR; Garg R; Vishnuprabu D; Ravi S; Subramanian L; Sahu BS; Iyer DR; Maghajothi S; Sharma S; Ravi MS; Khullar M; Munirajan AK; Gayen JR; Senapati S; Mullasari AS; Mohan V; Radha V; Naga Prasad SV; Mahapatra NR
Diabetes; 2022 Mar; 71(3):538-553. PubMed ID: 34862200
[TBL] [Abstract][Full Text] [Related]
3. Pancreastatin is an endogenous peptide that regulates glucose homeostasis.
Valicherla GR; Hossain Z; Mahata SK; Gayen JR
Physiol Genomics; 2013 Nov; 45(22):1060-71. PubMed ID: 24064537
[TBL] [Abstract][Full Text] [Related]
4. Pancreastatin: multiple actions on human intermediary metabolism in vivo, variation in disease, and naturally occurring functional genetic polymorphism.
O'Connor DT; Cadman PE; Smiley C; Salem RM; Rao F; Smith J; Funk SD; Mahata SK; Mahata M; Wen G; Taupenot L; Gonzalez-Yanes C; Harper KL; Henry RR; Sanchez-Margalet V
J Clin Endocrinol Metab; 2005 Sep; 90(9):5414-25. PubMed ID: 15956083
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel target for the dysglycemic chromogranin A fragment pancreastatin: interaction with the chaperone GRP78 to influence metabolism.
Biswas N; Friese RS; Gayen JR; Bandyopadhyay G; Mahata SK; O'Connor DT
PLoS One; 2014; 9(1):e84132. PubMed ID: 24465394
[TBL] [Abstract][Full Text] [Related]
6. Functional genetic variants of the catecholamine-release-inhibitory peptide catestatin in an Indian population: allele-specific effects on metabolic traits.
Sahu BS; Obbineni JM; Sahu G; Allu PK; Subramanian L; Sonawane PJ; Singh PK; Sasi BK; Senapati S; Maji SK; Bera AK; Gomathi BS; Mullasari AS; Mahapatra NR
J Biol Chem; 2012 Dec; 287(52):43840-52. PubMed ID: 23105094
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma levels of pancreastatin (PST) in patients with non-insulin-dependent diabetes mellitus (NIDDM).
Funakoshi A; Tateishi K; Shinozaki H; Matsumoto M; Wakasugi H
Regul Pept; 1990 Sep; 30(2):159-64. PubMed ID: 2274680
[TBL] [Abstract][Full Text] [Related]
8. Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin.
Sánchez-Margalet V; González-Yanes C; Najib S; Santos-Alvarez J
Regul Pept; 2010 Apr; 161(1-3):8-14. PubMed ID: 20184923
[TBL] [Abstract][Full Text] [Related]
9. Pancreastatin inhibits insulin action in rat adipocytes.
Sánchez-Margalet V; González-Yanes C
Am J Physiol; 1998 Dec; 275(6):E1055-60. PubMed ID: 9843749
[TBL] [Abstract][Full Text] [Related]
10. A novel pathway of insulin sensitivity in chromogranin A null mice: a crucial role for pancreastatin in glucose homeostasis.
Gayen JR; Saberi M; Schenk S; Biswas N; Vaingankar SM; Cheung WW; Najjar SM; O'Connor DT; Bandyopadhyay G; Mahata SK
J Biol Chem; 2009 Oct; 284(42):28498-509. PubMed ID: 19706599
[TBL] [Abstract][Full Text] [Related]
11. Pancreastatin, a chromogranin-A-derived peptide, inhibits insulin-stimulated glycogen synthesis by activating GSK-3 in rat adipocytes.
González-Yanes C; Sánchez-Margalet V
Biochem Biophys Res Commun; 2001 Nov; 289(1):282-7. PubMed ID: 11708813
[TBL] [Abstract][Full Text] [Related]
12. Pancreastatin-dependent inflammatory signaling mediates obesity-induced insulin resistance.
Bandyopadhyay GK; Lu M; Avolio E; Siddiqui JA; Gayen JR; Wollam J; Vu CU; Chi NW; O'Connor DT; Mahata SK
Diabetes; 2015 Jan; 64(1):104-16. PubMed ID: 25048197
[TBL] [Abstract][Full Text] [Related]
13. The immunomodulatory functions of chromogranin A-derived peptide pancreastatin.
Ioannidis M; Mahata SK; van den Bogaart G
Peptides; 2022 Dec; 158():170893. PubMed ID: 36244579
[TBL] [Abstract][Full Text] [Related]
14. Glucose-dependent effects of pancreastatin on insulin and glucagon release.
von Schönfeld J; Kleimann J; Müller MK; Rünzi M; Goebell H
Int J Pancreatol; 1991 Oct; 10(2):143-9. PubMed ID: 1748828
[TBL] [Abstract][Full Text] [Related]
15. Discovery of pancreastatin inhibitor PSTi8 for the treatment of insulin resistance and diabetes: studies in rodent models of diabetes mellitus.
Hossain Z; Valicherla GR; Gupta AP; Syed AA; Riyazuddin M; Chandra S; Siddiqi MI; Gayen JR
Sci Rep; 2018 Jun; 8(1):8715. PubMed ID: 29880906
[TBL] [Abstract][Full Text] [Related]
16. Reprint of: Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin.
Sánchez-Margalet V; González-Yanes C; Najib S; Santos-Álvarez J
Regul Pept; 2010 Nov; 165(1):71-7. PubMed ID: 20934461
[TBL] [Abstract][Full Text] [Related]
17. Studies of the dysglycemic peptide, pancreastatin, using a human forearm model.
Cadman PE; Rao F; Mahata SK; O'Connor DT
Ann N Y Acad Sci; 2002 Oct; 971():528-9. PubMed ID: 12438174
[TBL] [Abstract][Full Text] [Related]
18. Galanin and pancreastatin inhibit stimulated insulin secretion in the mouse: comparison of effects.
Lindskog S; Ahrén B
Horm Res; 1988; 29(5-6):237-40. PubMed ID: 2464535
[TBL] [Abstract][Full Text] [Related]
19. Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia induced obesity and inflammation mediated insulin resistance via MAPK/NOX3-JNK pathway.
Gupta AP; Syed AA; Garg R; Goand UK; Singh P; Riyazuddin M; Valicherla GR; Husain A; Gayen JR
Eur J Pharmacol; 2019 Dec; 864():172723. PubMed ID: 31586632
[TBL] [Abstract][Full Text] [Related]
20. A common genetic variant of the chromogranin A-derived peptide catestatin is associated with atherogenesis and hypertension in a Japanese population.
Choi Y; Miura M; Nakata Y; Sugasawa T; Nissato S; Otsuki T; Sugawara J; Iemitsu M; Kawakami Y; Shimano H; Iijima Y; Tanaka K; Kuno S; Allu PK; Mahapatra NR; Maeda S; Takekoshi K
Endocr J; 2015; 62(9):797-804. PubMed ID: 26211667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
